TheraRadar
Clinical-Stage Companies / Humanis Saglık Anonim Sirketi

Humanis Saglık Anonim Sirketi

Pre-Approval PRO BETA
35
Total Trials
1
Phase 3
2
Phase 2
0
Recruiting
173
Score

Pipeline by Phase

Phase 3
1
Phase 2
2
Phase 1
34

Therapeutic Focus

Type 2 Diabetes Mellitus (T2DM) Hypercholesterolaemia PAH Pulmonary Arterial Hypertension Epilepsy

Clinical Trials (35)

NCT06084663 Phase 3 COMPLETED

Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects

Started: 2/15/2023

NCT07372118 Phase 1 COMPLETED

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition

Started: 9/27/2025

NCT07278349 Phase 1 COMPLETED

Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets

Started: 9/21/2025

NCT07266766 Phase 1 COMPLETED

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg

Started: 8/5/2025

NCT07266779 Phase 1 COMPLETED

Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets in Healthy, Adult, Human Subjects Under Fed Condition.

Started: 8/22/2025

NCT07266792 Phase 1 COMPLETED

Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpiprazole)

Started: 6/22/2025

NCT07213895 Phase 1 COMPLETED

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets

Started: 5/21/2025

NCT06043297 Phase 1 COMPLETED

Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

Started: 2/23/2023

NCT07170852 Phase 1 COMPLETED

Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets

Started: 5/21/2025

NCT07098585 Phase 1 COMPLETED

To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard Lisdexamfetamine Dimesylate in Healthy, Adult, Human Subjects Under Fasting Conditions.

Started: 5/26/2025

NCT07042828 Phase 1 COMPLETED

To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions

Started: 4/30/2025

NCT07039890 Phase 1 COMPLETED

To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions.

Started: 3/8/2025

NCT06932198 Phase 1 COMPLETED

Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400 mcg Selexipag)

Started: 1/9/2025

NCT06592300 Phase 1 COMPLETED

Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects

Started: 7/6/2024

NCT06932159 Phase 1 COMPLETED

Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets

Started: 12/23/2024

NCT06923956 Phase 1 COMPLETED

Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.

Started: 12/4/2024

NCT06922253 Phase 1 COMPLETED

Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97 mg/103 mg)

Started: 12/28/2024

NCT06553937 Phase 1 COMPLETED

Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg

Started: 5/10/2024

NCT06557603 Phase 1 COMPLETED

Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream

Started: 3/6/2024

NCT06553924 Phase 1 COMPLETED

Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg

Started: 5/14/2024

NCT06484673 Phase 1 COMPLETED

Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets

Started: 4/21/2024

NCT06450223 Phase 1 COMPLETED

Bioequivalence Study of Perampanel Tablets 12 mg

Started: 9/14/2023

NCT06450184 Phase 1 COMPLETED

Bioequivalence Study of Pimavanserin 34 mg Capsule

Started: 1/11/2024

NCT06450262 Phase 1 COMPLETED

Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets

Started: 1/4/2024

NCT06450236 Phase 1 COMPLETED

Bioequivalence Study of Perampanel Tablets 10 mg

Started: 11/22/2023

NCT06450275 Phase 1 COMPLETED

Bioequivalence Study to Compare Dolutegravir 50mg Film-coated Tablets

Started: 1/3/2024

NCT06180057 Phase 1 COMPLETED

Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid)

Started: 6/12/2022

NCT06180096 Phase 1 COMPLETED

Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets

Started: 3/7/2023

NCT06180083 Phase 1 COMPLETED

Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray

Started: 3/24/2023

NCT06180109 Phase 1 COMPLETED

Bioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozin) 25 mg Film-coated Tablets of Boehringer Ingelheim International GmbH, Germany in Normal, Healthy, Adult, Human Subjects Under Fasting Condition

Started: 7/30/2023

NCT06180070 Phase 1 COMPLETED

Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol)

Started: 8/29/2023

NCT05082662 Phase 1 COMPLETED

Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated Tablet

Started: 8/25/2020

NCT05082753 Phase 1 COMPLETED

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Started: 11/19/2020

NCT04817800 Phase 1 COMPLETED

To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray

Started: 3/25/2021

NCT04639869 Phase 1 COMPLETED

Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions

Started: 6/26/2019

Drug Candidates

Empagliflozin / Metformin HCl XR Tablets Synjardy® XR (empagliflozin and metformin hydrochloride extended-release Tablets) Vonoprazan Tablets VOQUEZNA® Tablets Ertugliflozin/Metformin film coated tablets Segluromet film coated tablets Brexpiprazole Film Coated Tablets RXULTI film coated tablet Empagliflozin/Linagliptin/Metformin HCL Trijardy® XR Extended release film coated tablets
Activity Status: Active
Last Trial Started: 9/27/2025
Last Trial Ended: 1/7/2026
Trials (12 months): 8
Completed Trials: 35
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.